As my oncologist, Professor Sanjay Popat [of the Royal Marsden Hospital in London] recently surmised: 'By all predictions, Mick shouldn't be here. This is down to me becoming the first mesothelioma patient worldwide to receive a cancer drug called vismodegib. I had a kind of mesothelioma which, he advised, was the best to treat — epitheloid mesothelioma is slower to spread. As time went by, I came to the simple conclusion that there was nothing, bar nothing, that I cared for more than my family. In all probability, that impact fell most directly on the children, and every so often the hurt and confusion came through.

Source: Daily Mail August 10, 2020 21:13 UTC